 AxoGen, Inc. NASDAQ:AXGN Q1 2022 Results Conference Call May 4, 2022 4:30 PM ET Company Participants Ed Joyce - Director, IR Karen Zaderej - Chairman, President CEO Peter Mariani - EVP CFO Erick DeVinney - VP of Peripheral Nerve Science Clinical Innovation Conference Call Participants Erin Fahey - SVB Leerink Frank Pinal - Jefferies Ross Osborn - Cantor Fitzgerald Dave Turkaly - JMP Securities Operator Good day, ladies and gentlemen, and welcome to the AxoGen, Inc. Reports First Quarter Earnings Call. Operator Instructions At this time, it is my pleasure to turn the floor over to your host, Ed Joyce. 